ILIKA PLC
IGE | IL
Overview
Corporate Details
- ISIN(s):
- GB00B608Z994 (+2 more)
- LEI:
- 213800TMDNIE3Z8XXD26
- Country:
- United Kingdom
- Address:
- UNIT 10A, THE QUADRANGLE, SO51 9DL ROMSEY
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
ImmuPharma is an AIM-listed biopharmaceutical company developing peptide-based therapies for autoimmune diseases and anti-infectives.Ê Its lead program, P140, is in Phase 3 trials for SLE.Ê The company aims to build a robust pipeline through strategic partnerships and licensing, maximizing shareholder value.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-11 15:09 |
Earnings Release
Notice of Results
|
English | 12.7 KB | |
| 2025-06-03 14:57 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 22.5 KB | |
| 2025-05-22 15:16 |
Capital/Financing Update
Retail Offer for up to £0.5 million
|
English | 43.6 KB | |
| 2025-05-07 11:03 |
Regulatory News Service
Ilika announces 2025 Investor Day
|
English | 12.4 KB | |
| 2025-03-06 08:00 |
Regulatory News Service
Goliath Development Progress
|
English | 14.6 KB | |
| 2025-02-27 08:00 |
Directors' Dealings
Award & Exercise of Share Options
|
English | 98.2 KB | |
| 2025-02-06 16:49 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 21.9 KB | |
| 2025-02-05 08:00 |
Regulatory News Service
Goliath Scale-up Progress
|
English | 15.1 KB | |
| 2025-01-21 08:00 |
Earnings Release
Half-year Results
|
English | 178.2 KB | |
| 2025-01-09 08:00 |
Regulatory News Service
Stereax Equipment Commissioning Completed
|
English | 14.4 KB | |
| 2024-12-19 08:00 |
Regulatory News Service
Appointment of Nominated Adviser and Sole Broker
|
English | 9.8 KB | |
| 2024-11-22 15:18 |
Board/Management Change
AIM Rule 17 Schedule 2(g) Update
|
English | 13.9 KB | |
| 2024-11-20 08:00 |
Regulatory News Service
Goliath D6 milestone reached
|
English | 17.6 KB | |
| 2024-11-15 08:00 |
Earnings Release
Trading Update & Notice of Half-Year Results
|
English | 24.4 KB | |
| 2024-10-10 14:49 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 22.2 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
|
Biogened Spolka Akcyjna | Poland | BGD | |
|
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
|
BOIRON | France | BOI | |
|
Bonyf N.V. | Belgium | MLBON | |
|
Bosnalijek d.d. Sarajevo | Bosnia and Herzegovina | BSNL | |
|
Calliditas Therapeutics | Sweden | CALTX |